JP2012528865A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528865A5
JP2012528865A5 JP2012514033A JP2012514033A JP2012528865A5 JP 2012528865 A5 JP2012528865 A5 JP 2012528865A5 JP 2012514033 A JP2012514033 A JP 2012514033A JP 2012514033 A JP2012514033 A JP 2012514033A JP 2012528865 A5 JP2012528865 A5 JP 2012528865A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
con
halo
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012514033A
Other languages
English (en)
Japanese (ja)
Other versions
JP5850459B2 (ja
JP2012528865A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/036832 external-priority patent/WO2010141424A1/en
Publication of JP2012528865A publication Critical patent/JP2012528865A/ja
Publication of JP2012528865A5 publication Critical patent/JP2012528865A5/ja
Application granted granted Critical
Publication of JP5850459B2 publication Critical patent/JP5850459B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012514033A 2009-06-02 2010-06-01 11βヒドロキシステロイドデヒドロゲナーゼ1のカルバマート及びウレアインヒビター Expired - Fee Related JP5850459B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21759309P 2009-06-02 2009-06-02
US61/217,593 2009-06-02
US26940609P 2009-06-24 2009-06-24
US61/269,406 2009-06-24
PCT/US2010/036832 WO2010141424A1 (en) 2009-06-02 2010-06-01 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1

Publications (3)

Publication Number Publication Date
JP2012528865A JP2012528865A (ja) 2012-11-15
JP2012528865A5 true JP2012528865A5 (enExample) 2013-07-18
JP5850459B2 JP5850459B2 (ja) 2016-02-03

Family

ID=42315408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012514033A Expired - Fee Related JP5850459B2 (ja) 2009-06-02 2010-06-01 11βヒドロキシステロイドデヒドロゲナーゼ1のカルバマート及びウレアインヒビター

Country Status (6)

Country Link
US (1) US9163012B2 (enExample)
EP (1) EP2438043A1 (enExample)
JP (1) JP5850459B2 (enExample)
AR (1) AR076936A1 (enExample)
TW (1) TW201103910A (enExample)
WO (1) WO2010141424A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5451611B2 (ja) 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20110002492A (ko) 2008-05-01 2011-01-07 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
CA2729993A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010011314A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
JP5679997B2 (ja) 2009-02-04 2015-03-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
AR076936A1 (es) 2009-06-02 2011-07-20 Vitae Pharmaceuticals Inc Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1
ES2350077B1 (es) 2009-06-04 2011-11-04 Laboratorios Salvat, S.A. Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1.
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2496589B1 (en) 2009-11-05 2014-03-05 Boehringer Ingelheim International GmbH Novel chiral phosphorus ligands
EP2576570A1 (en) 2010-05-26 2013-04-10 Boehringer Ingelheim International GmbH 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
JP5926727B2 (ja) 2010-07-28 2016-05-25 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 置換イミダゾ[1,2−b]ピリダジン
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
MX336865B (es) 2011-04-07 2016-02-04 Bayer Pharma AG Imidazopiridazinas como inhibidores de quinasa akt.
WO2014184272A2 (en) * 2013-05-14 2014-11-20 Medizinische Hochschule Hannover Means and methods for treating cancer
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives
CN115340481B (zh) * 2022-08-08 2025-12-12 广州谷森制药有限公司 一种采用固载镍催化工业化生产氘代医药中间体的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270302A (en) 1988-12-21 1993-12-14 Abbott Laboratories Derivatives of tetrapeptides as CCK agonists
US5912114A (en) 1997-09-12 1999-06-15 Johnson & Johnson Medical, Inc. Wound diagnosis by quantitating cortisol in wound fluids
TWI221102B (en) * 2002-08-30 2004-09-21 Sumitomo Heavy Industries Laser material processing method and processing device
CN1744899A (zh) * 2002-12-13 2006-03-08 史密丝克莱恩比彻姆公司 作为ccr5拮抗剂的哌啶衍生物
TW200510405A (en) * 2003-05-13 2005-03-16 Schering Corp Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
JP5242390B2 (ja) * 2006-06-27 2013-07-24 旭硝子株式会社 液晶光学素子および液晶光学素子の製造方法
EP2064187A2 (en) 2006-08-25 2009-06-03 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
JP5223864B2 (ja) 2007-06-27 2013-06-26 大正製薬株式会社 11β−HSD1阻害活性を有する化合物
WO2009020140A1 (ja) * 2007-08-06 2009-02-12 Dainippon Sumitomo Pharma Co., Ltd. アダマンチルウレア誘導体
CA2702950A1 (en) * 2007-10-16 2009-04-23 Northeastern University Methods and compounds for modulating cannabinoid activity
TW200944526A (en) 2008-04-22 2009-11-01 Vitae Pharmaceuticals Inc Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
AR076936A1 (es) 2009-06-02 2011-07-20 Vitae Pharmaceuticals Inc Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1

Similar Documents

Publication Publication Date Title
JP2011518218A5 (enExample)
JP2013505946A5 (enExample)
JP2012092103A5 (enExample)
JP2019518766A5 (enExample)
JP2012515776A5 (enExample)
JP2016516043A5 (enExample)
JP2017526677A5 (enExample)
JP2016506960A5 (enExample)
JP2016503793A5 (enExample)
JP2013505945A5 (enExample)
JP2015508092A5 (enExample)
JP2017509586A5 (enExample)
JP2013504593A5 (enExample)
JP2011515483A5 (enExample)
JP2014051526A5 (enExample)
JP2018538248A5 (enExample)
JP2013537203A5 (enExample)
JP2012513416A5 (enExample)
JP2013542261A5 (enExample)
JP2014500861A5 (enExample)
JP2011529918A5 (enExample)
JP2020500916A5 (enExample)
JP2011137045A5 (enExample)
JP2017511321A5 (enExample)
JP2015535847A5 (enExample)